Anna Kramvis to Liver Neoplasms
                            
                            
                                This is a "connection" page, showing publications Anna Kramvis has written about Liver Neoplasms.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            7,438
         
        
        
     
 
    
        
        - 
            The Complex Role of HBeAg and Its Precursors in the Pathway to Hepatocellular Carcinoma. Viruses. 2023 03 27; 15(4).
            
            
                Score: 0,783
            
         
        
        - 
            The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation. Front Immunol. 2021; 12:661204.
            
            
                Score: 0,686
            
         
        
        - 
            In vitro expression of precore proteins of hepatitis B virus subgenotype A1 is affected by HBcAg, and can affect HBsAg secretion. Sci Rep. 2021 04 14; 11(1):8167.
            
            
                Score: 0,684
            
         
        
        - 
            The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways. Viruses. 2020 07 10; 12(7).
            
            
                Score: 0,649
            
         
        
        - 
            Molecular characterization of hepatitis B virus isolated from Black South African cancer patients, with and without hepatocellular carcinoma. Arch Virol. 2020 Aug; 165(8):1815-1825.
            
            
                Score: 0,645
            
         
        
        - 
            The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells. 2019 11 24; 8(12).
            
            
                Score: 0,621
            
         
        
        - 
            Liver cancer mortality trends in South Africa: 1999-2015. BMC Cancer. 2018 Aug 07; 18(1):798.
            
            
                Score: 0,568
            
         
        
        - 
            Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012. PLoS One. 2018; 13(5):e0196057.
            
            
                Score: 0,558
            
         
        
        - 
            Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya. Infect Genet Evol. 2013 Dec; 20:103-10.
            
            
                Score: 0,403
            
         
        
        - 
            Molecular characterization of hepatitis B virus in liver disease patients and asymptomatic carriers of the virus in Sudan. BMC Infect Dis. 2013 Jul 18; 13:328.
            
            
                Score: 0,400
            
         
        
        - 
            Distinct mutant hepatitis B virus genomes, with alterations in all four open reading frames, in a single South African hepatocellular carcinoma patient. Virus Res. 2012 Jan; 163(1):59-65.
            
            
                Score: 0,351
            
         
        
        - 
            Comparative Proteomic Analysis of Huh7 Cells Transfected with Sub-Saharan African Hepatitis B Virus (Sub)genotypes Reveals Potential Oncogenic Factors. Viruses. 2024 Jun 29; 16(7).
            
            
                Score: 0,214
            
         
        
        - 
            Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan Africa. Lancet Gastroenterol Hepatol. 2022 11; 7(11):1036-1048.
            
            
                Score: 0,186
            
         
        
        - 
            Hepatitis B virus precore mutants in serum and liver of Southern African Blacks with hepatocellular carcinoma. J Hepatol. 1998 Jan; 28(1):132-41.
            
            
                Score: 0,136
            
         
        
        - 
            Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology. BMC Cancer. 2017 12 28; 17(1):894.
            
            
                Score: 0,136
            
         
        
        - 
            Hepatitis B e Antigen Expression by Hepatitis B Virus Subgenotype A1 Relative to Subgenotypes A2 and D3 in Cultured Hepatocellular Carcinoma (Huh7) Cells. Intervirology. 2016; 59(1):48-59.
            
            
                Score: 0,124
            
         
        
        - 
            Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India. World J Gastroenterol. 2013 Dec 28; 19(48):9294-306.
            
            
                Score: 0,103
            
         
        
        - 
            Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology. 2006 Mar; 130(3):703-14.
            
            
                Score: 0,060
            
         
        
        - 
            Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans. J Med Virol. 2005 Apr; 75(4):513-21.
            
            
                Score: 0,056
            
         
        
        - 
            A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol. 2019 07; 4(7):545-558.
            
            
                Score: 0,037
            
         
        
        - 
            High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology. 1999 Mar; 29(3):946-53.
            
            
                Score: 0,037